The Importance of NAT Testing in Ensuring Blood Safety and the Prevention of Transfusion-Transmitted Infections
Every year, millions of people worldwide receive blood transfusions or blood products. Sansure found through survey data, the blood screening market was valued at USD 1.8 billion in 2020 and is expected to reach USD 4.6 billion by 2028, growing at a CAGR of 11.9% from 2021 to 2028. Therefore, blood safety is a top priority, especially given the high prevalence of HIV, HBV, and HCV in the general population.

The Role of NAT Testing in Blood Safety
Therefore, many developed countries have implemented NAT in blood donor screening to reduce the risk of transfusion-transmitted virus infection. NAT can detect HIV, HBV, and HCV cases in blood donor samples not detected by serological testing. In addition, NAT can shorten the window period to 10.34 days for HBV, 1.34 days for HCV, and 2.93 days for HIV. The implementation of NAT test blood has revolutionized blood safety protocols, ensuring a higher level of protection for recipients.
Sansure’s reliable NAT Technology
Sansure, a reliable innovator in diagnostic solutions, offers state-of-the-art NAT testing technology that ensures enhanced blood safety. By utilizing Sansure’s advanced NAT tests, healthcare facilities can significantly reduce the risk of transfusion-transmitted infections, providing peace of mind to both patients and healthcare providers.
Conclusion
In conclusion, the implementation of NAT testing in blood donor screening plays a crucial role in safeguarding blood supplies worldwide. With Sansure’s advanced NAT technology, healthcare facilities can detect HIV, HBV, and HCV infections more accurately and swiftly, thereby improving blood safety standards and enhancing public health outcomes. Embracing NAT testing is a vital step towards ensuring the well-being of individuals in need of blood transfusions.